Story information Teaser:  A Plaistow woman burned and blinded by an anti-inflammatory drug has won her lawsuit against the PHARMACEUTICAL company that's been marketing the medication for more than three decades. Synopsis:  A nine-member jury has unanimou

Cumberland PHARMACEUTICALs Inc. , a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the Stifel Nicolaus 2010 Healthcare Conference at the Four Seaso

MERGERS & ACQUISITIONS: Verdict paves way for Sun takeover of Taro Will have to pay $40 m more for promoters' stake. After three years of protracted, multi-country litigation, Sun PHARMACEUTICAL saw light at the end of the tunnel on its $454-million propo

NEW YORK, Sept. 8 (UPI) -- PHARMACEUTICAL giant Bristol-Myer Squibb has agreed to purchase Seattle biotechnology firm ZymoGenetics for $885 million, the companies said. Bristol-Myer Squibb - ZymoGenetics - Biotechnology - NEW YORK - Business

More trouble is brewing for Sun PHARMACEUTICAL Industries (Sun Pharma). The United States Food and Drug Administration (USFDA) has issued a warning letter to it for manufacturing practice violations at its Cranbury facility in New Jersey. The regulator ha

Pharmaceutical products may be indispensable to many people, but when flushed down the drain or disposed of in other inappropriate ways, they can also contaminate waterways and harm fish, wildlife, and

PRLog (Press Release) - Sep 08, 2010 - Interview with: Diarmuid Jeffreys, Author of 'Aspirin: The Remarkable Story of a Wonder Drug' The PHARMACEUTICAL industry can rebrand drugs and regenerate a second round

CHICAGO , Sept. 8 -- Seven Summits Research issues critical PriceWatch com/s/090810A for Seven Summits Strategic Investments' PriceWatch Alerts. Seven Summits Investment Research is an independent investment

ISPE Risk-MaPP 2010 Conference, Dedicated Facilities, Cross Contamination and the Risk-MaPP Approach, will feature North American launch of ISPE Baseline® Guide: Risk-Based Manufacturing of PHARMACEUTICAL Products (Risk-MaPP), on October 4-5, 2010. Attend

DURHAM, N.C., Sept. 8, 2010 (GLOBE NEWSWIRE) -- Curaxis PHARMACEUTICAL Corp (OTCBB:CURX) today announced an update on the Company's clinical development plans for Memryte, its candidate to treat mild-to-moderate

Teva PHARMACEUTICAL Industries Ltd. today announced the publication of results from a real-life observational study of the General Practice Research Database , which revealed that asthma patients treated with QVARĂ‚® , either as initial therapy or with an

Aoxing PHARMACEUTICAL Company, Inc. (NYSE Amex: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products

Nautilus Neurosciences, Inc. , a neurology-focused specialty PHARMACEUTICAL company headquartered in New Jersey, and APR Applied Pharma Research s.a. , a leading drug developer and delivery technology provider based in Switzerland, announced today that CA

India is keen to invest in Peru's hydrocarbon, mineral, PHARMACEUTICAL and agriculture sectors through joint ventures and deepen the economic engagement with the South American country.

Nasdaq: ENMD - News ), a clinical-stage PHARMACEUTICAL company focused on the development of ENMD-2076, its proprietary Aurora A/angiogenic kinase inhibitor for the treatment of cancer, today announced that on

70% of American Physicians State They Would Make the New Drugs a Standard Therapy Treatment PARSIPPANY, NJ , Sept. 8 /PRNewswire/ - Ipsos Vantis, a major market research supplier to the PHARMACEUTICAL industry, recently conducted surveys among physicians

Sun PHARMACEUTICAL Industries Ltd. said it may have to pay $37 million to boost its stake in Taro Pharmaceutical Industries Ltd. after Israel's highest court ruled Sun could proceed with its takeover offer for Taro.

There are currently no reliably safe and effective treatments for morning sickness, according to Cochrane researchers who conducted a systematic review of the available evidence. There was very limited evidence for all PHARMACEUTICAL and alternative medic

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene Euronext, a bio-PHARMACEUTICAL company specialized in the development